Back to top

Takeda dengue vaccine receives marketing authorization from India DCGI

Takeda (TAK) announced that India’s Drug Controller General of India, or DCGI, has granted marketing authorization for Takeda’s dengue vaccine for ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Takeda Pharmaceutical Co. (TAK)